InVitria Launches Optibumin® 25: A Groundbreaking 25% Recombinant Human Serum Albumin Designed for Closed-System Biomanufacturing InVitria, a recognized innovator in the development of recombinant, chemically defined components for biomanufacturing, has announced the commercial launch of Optibumin® 25 — a first-of-its-kind…
California Center for Reproductive Health Recognized by Newsweek as One of America’s Best Fertility Clinics for Third Year Running The California Center for Reproductive Health (CCRH), widely regarded as one of the premier fertility clinics in the country, has once…
Shearwater Health Earns Great Place to Work® Certification Across U.S., Philippines, and India, Showcasing a Unified Commitment to Employee Well-Being Shearwater Health, a global leader in clinician-led clinical solutions, has proudly earned the esteemed Great Place to Work® Certification across…
Qualthera Health Corporation Launches Qualthera Pharmaceuticals Ltd. Co. to Lead Innovation in Drug Repurposing and Targeted Delivery Qualthera Health Corporation, a leader in personalized medicine through its network of patient-centered compounding pharmacies, has announced the official launch of Qualthera Pharmaceuticals…
Edgewood Oncology Unveils Compelling Preclinical Data Supporting BTX-A51 in Liposarcoma at AACR Annual Meeting 2025 Edgewood Oncology, a clinical-stage biotechnology company dedicated to advancing targeted cancer therapies, today announced new preclinical efficacy data for BTX-A51 in liposarcoma (LPS). The data,…
Mythic Therapeutics Presents Promising Preclinical Data Demonstrating Broad Antitumor Efficacy of MYTX-011 at the 2025 AACR Annual Meeting Mythic Therapeutics, a clinical-stage biotechnology company pioneering the next generation of antibody-drug conjugates (ADCs), today unveiled compelling preclinical data supporting the broad…
Devonian Health Group Inc. Announces Reinstatement of Trading on TSX Venture Exchange Following Resolution of Cease Trade Order Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a late-stage botanical pharmaceutical corporation, today announced a significant corporate…
Puma Biotechnology Showcases Promising Neratinib Combination Data at AACR Annual Meeting 2025 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company specializing in the development of innovative cancer treatments, has presented new clinical data on its lead drug candidate, neratinib (NERLYNX®),…
Agenus Presents Promising BOT/BAL Neoadjuvant Pan-Cancer Data from NEOASIS Study at AACR Annual Meeting Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company focused on developing therapies designed to activate the body’s immune system to fight cancer, announced the presentation of…
LEAP Consulting Group Accelerates Clinical Lab Digital Transformation with Appointment of Dr. Heather E. Williams as Practice Principal, Life Sciences LEAP Consulting Group, a boutique digital consultancy recognized for its domain expertise in the clinical diagnostics space, has announced a…
Fellow Health to Present Groundbreaking Research on Prostate Cancer Biomarkers and Mail-In PVSA Testing at AUA 2025 Fellow Health, a pioneering healthcare company dedicated to advancing male reproductive health through innovative, patient-centered diagnostics, today announced that it will present four…
Contineum Therapeutics Names Dr. Timothy Watkins as Chief Medical Officer and Head of Development, Signaling Strategic Growth in Clinical Pipeline Contineum Therapeutics, Inc. (Nasdaq: CTNM), a clinical-stage biopharmaceutical company advancing novel treatments for serious central nervous system (CNS) and immunologic…